Ditch Labs secures $3.25 million to treat nicotine addiction with tech

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Armed with $3.25 million CAD in seed funding, Montréal-based healthtech start-up Ditch Labs wants to help smokers wean themselves off nicotine with its dual hardware-software solution. Ditch Labs’ solution consists of a medical nicotine vaporizer that facilitates controlled delivery and a complementary app that provides personalized support, progress tracking, and behavioural interventions. With this combo, the startup aims to address the physiological and psychological impacts of nicotine addiction simultaneously.

Ditch Labs presented at the OBIO® Investment Summit.

Arsheen Kaur
Previous

Recursion announces collaboration and $50 million investment from NVIDIA
Next

CHEO successfully evaluates in-house 3D printing as a solution to save time and money